Dao Xin
Impact in
-
- Bioactive Compounds and Antitumor Agents
-
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA modifications and cancer 2
- Angiogenesis and VEGF in Cancer 1
- Epigenetics and DNA Methylation 1
- Oncology 5
- Cancer Immunotherapy and Biomarkers 2
- HER2/EGFR in Cancer Research 1
- Co-authors
- Guanwei Fan (1 shared paper)Xiu Gao (1 shared paper)Yan Zhu (1 shared paper)Feng Wang (5 shared papers)Yao Lu (3 shared papers)Feng Wang (4 shared papers)Lulu Guan (4 shared papers)Yuanyuan Yang (2 shared papers)
- Journals
- Diseases of the Esophagus (1 paper)Frontiers in Molecular Biosciences (1 paper)OncoTargets and Therapy (1 paper)Recent Patents on Anti-Cancer Drug Discovery (1 paper)Journal of Inflammation Research (1 paper)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Dao Xin
18 papers receiving 255 citations
Peers
Comparison fields: 5 of 52
- Toxicology 14
- Oncology 63
- Pharmacology 18
- Molecular Biology 126
- Cancer Research 23
Countries citing papers authored by Dao Xin
This map shows the geographic impact of Dao Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dao Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dao Xin more than expected).
Fields of papers citing papers by Dao Xin
This network shows the impact of papers produced by Dao Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dao Xin. The network helps show where Dao Xin may publish in the future.
Co-authors
The 25 scholars most cited alongside Dao Xin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 121 | |
| 2 | 2019 | 33 | |
| 3 | 2021 | 23 | |
| 4 | 2022 | 13 | |
| 5 | 2022 | 11 | |
| 6 | 2005 | 11 | |
| 7 | 2018 | 7 | |
| 8 | 2023 | 6 | |
| 9 | 2024 | 5 | |
| 10 | 2023 | 5 | |
| 11 | 2021 | 5 | |
| 12 | 2024 | 5 | |
| 13 | 2024 | 4 | |
| 14 | 2023 | 3 | |
| 15 | 2022 | 3 | |
| 16 | 2021 | 3 | |
| 17 | 2018 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2026 | 0 | |
| 20 | 2025 | 0 |
About Dao Xin
Dao Xin is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Cancer Research, having authored 21 papers that have together received 260 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), RNA modifications and cancer (2 papers), Esophageal Cancer Research and Treatment (2 papers), HER2/EGFR in Cancer Research (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Epigenetics and DNA Methylation (1 paper) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Toxicology (14 citations), Oncology (63 citations), Pharmacology (18 citations), Molecular Biology (126 citations) and Cancer Research (23 citations). Dao Xin has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Guanwei Fan, Xiu Gao, Yan Zhu, Feng Wang, Yao Lu, Feng Wang, Lulu Guan, Yuanyuan Yang, Li Wang and Yu Chen. Their work appears in journals such as Diseases of the Esophagus, Frontiers in Molecular Biosciences, OncoTargets and Therapy, Recent Patents on Anti-Cancer Drug Discovery and Journal of Inflammation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.